LivaNova and Verily Announce First Patient Enrolled in Study to Evaluate Treatment Effectiveness for Patients Living with DepressionBusiness Wire • 04/26/21
LivaNova Receives FDA 510(k) Clearance for B-Capta, the New In-Line, Blood-Gas Monitoring System Integrated Into the S5 Heart-Lung MachineBusiness Wire • 04/20/21
Earnings Preview: LivaNova (LIVN) Q4 Earnings Expected to DeclineZacks Investment Research • 02/17/21
LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2020 ResultsBusiness Wire • 01/20/21
Living The LivaNova: 50% Upside Potential Is Under-Reflected In Current PricingSeeking Alpha • 12/12/20
LivaNova to Host Satellite Symposium on Advances in Neuromodulation at American Epilepsy Society AES2020 Virtual EventBusiness Wire • 12/04/20
LivaNova and Gyrus Capital Enter into Agreement for the Purchase of Heart Valve BusinessBusiness Wire • 12/03/20
LivaNova to Participate in the Piper Sandler 32nd Annual Virtual Healthcare ConferenceBusiness Wire • 11/23/20
Earnings Preview: LivaNova (LIVN) Q3 Earnings Expected to DeclineZacks Investment Research • 10/22/20
LivaNova Presents New Data at European Association for Cardio-Thoracic Surgery Annual Meeting Demonstrating Benefits of Perceval Sutureless ValveBusiness Wire • 10/12/20